
Aspirin May Cut Dementia Risk for Specific Genetic Subgroup, New Analysis Suggests
A new analysis of a large randomized trial indicates that daily low-dose aspirin may reduce dementia risk by 70 percent for individuals with specific platelet-related genetic markers. However, this benefit comes with a doubled risk of serious bleeding, and experts caution against self-prescribing. The findings suggest that previous trials may have missed benefits by averaging results across all participants, highlighting the potential for personalized prevention strategies.












